Pasquale Pisapia

About Pasquale Pisapia

Pasquale Pisapia, With an exceptional h-index of 30 and a recent h-index of 30 (since 2020), a distinguished researcher at Università degli Studi di Napoli Federico II, specializes in the field of Molecular pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Spotlight: Rising stars in cytology

A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers

Economic assessment of NGS testing workflow for NSCLC in a healthcare setting

The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report

Interobserver variability in cytopathology: How much do we agree?

Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system

PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories

Pasquale Pisapia Information

University

Position

___

Citations(all)

2644

Citations(since 2020)

2417

Cited By

973

hIndex(all)

30

hIndex(since 2020)

30

i10Index(all)

63

i10Index(since 2020)

62

Email

University Profile Page

Google Scholar

Pasquale Pisapia Skills & Research Interests

Molecular pathology

Top articles of Pasquale Pisapia

Spotlight: Rising stars in cytology

Cancer Cytopathology

2022/8

A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers

Clinical and Experimental Medicine

2024/4/10

Economic assessment of NGS testing workflow for NSCLC in a healthcare setting

Heliyon

2024/4/5

The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database

Lung Cancer

2024/4/5

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report

2024/4

Interobserver variability in cytopathology: How much do we agree?

2024/3/27

Pasquale Pisapia
Pasquale Pisapia

H-Index: 17

Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system

2024/2/2

Pasquale Pisapia
Pasquale Pisapia

H-Index: 17

PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories

Pharmacogenomics

2024/2

The role of liquid biopsy in epithelial ovarian cancer: state of the art

2024/1/11

Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma

European Journal of Cancer

2024/1/1

Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions

Journal of Molecular Pathology

2023/10/31

Pasquale Pisapia
Pasquale Pisapia

H-Index: 17

Umberto Malapelle
Umberto Malapelle

H-Index: 28

The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier?

2023/10/3

A Multi-Institutional Study on 4,651 Thyroid FNAs, Evaluating Different Local Cytopathology Practices by Using Molecular Tests as Quality Metrics, with a Focus on the …

Journal of the American Society of Cytopathology

2023/9/1

Pasquale Pisapia
Pasquale Pisapia

H-Index: 17

Umberto Malapelle
Umberto Malapelle

H-Index: 28

P-161 MiR181c/d regulates sensitivity to cisplatin/gemcitabine by targeting SIRT1 in cholangiocarcinoma

Annals of Oncology

2023/6/1

P-123 CD73high biliary tract cancer (BTC) is a molecularly defined subtype with distinct clinical implications

Annals of Oncology

2023/6/1

Multiple predictive biomarker testing in melanoma: Another challenge in identifying the optimal approach on cytological samples

Cytopathology

2023/5

Pasquale Pisapia
Pasquale Pisapia

H-Index: 17

Umberto Malapelle
Umberto Malapelle

H-Index: 28

Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study

Journal of Clinical Pathology

2023/3/1

Pasquale Pisapia
Pasquale Pisapia

H-Index: 17

Umberto Malapelle
Umberto Malapelle

H-Index: 28

An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples

Diagnostics

2023/2/8

Integrated analysis of genomic and transcriptomic profiles to examine CD73/NT5E as a driver of drug-resistance and immunosuppression in biliary cancer (BTC).

Nature communications

2023/3/22

See List of Professors in Pasquale Pisapia University(Università degli Studi di Napoli Federico II)